• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过生物信息学分析和实验验证,S100P 作为胰腺癌中 miR-495 的靶标。

S100P acts as a target of miR-495 in pancreatic cancer through bioinformatics analysis and experimental verification.

机构信息

Department of Gastroenterology, Weifang People's Hospital, Weifang, China.

Outpatient Department, Liaocheng Chiping District People's Hospital, Liaocheng, China.

出版信息

Kaohsiung J Med Sci. 2021 Jul;37(7):562-571. doi: 10.1002/kjm2.12383. Epub 2021 May 5.

DOI:10.1002/kjm2.12383
PMID:33949774
Abstract

S100 calcium binding protein P (S100P) and miR-495 are aberrantly expressed and exert essential roles in cancers. However, the mechanisms of miR-495-S100P in pancreatic cancer are yet to be illustrated. Thus, we explored the regulatory functions of miR-495-S100P axis in pancreatic adenocarcinoma cells growth and invasion. In this study, we identified that S100P was upregulated in pancreatic adenocarcinoma by bioinformatics analysis of the GEO (Gene Expression Omnibus database) microarray dataset (GSE16515). Western blotting and luciferase reporter gene analysis exhibited that miR-495 negatively determined the level of S100P via binging to its 3'-untranslated regions (3'-UTRs). A series of functional experiments indicated that upregulation of miR-495 or S100P knockdown suppressed pancreatic adenocarcinoma cells proliferation, invasion, and promoted apoptosis. Furthermore, the expression of S100P was negatively associated with the level of miR-495 in The Cancer Genome Atlas (TCGA) pancreatic adenocarcinoma case-cohort. Besides, reintroduction of S100P debilitated the anti-cancer action of miR-495 in pancreatic adenocarcinoma cells. Our data indicated that miR-495 performed suppressive roles in pancreatic adenocarcinoma through targeting S100P.

摘要

S100 钙结合蛋白 P(S100P)和 miR-495 表达异常,在癌症中发挥重要作用。然而,miR-495-S100P 在胰腺癌中的作用机制尚不清楚。因此,我们探讨了 miR-495-S100P 轴在胰腺腺癌细胞生长和侵袭中的调节功能。在这项研究中,我们通过对 GEO(基因表达综合数据库)微阵列数据集(GSE16515)的生物信息学分析,确定 S100P 在胰腺腺癌中上调。Western blot 和荧光素酶报告基因分析表明,miR-495 通过结合其 3'-非翻译区(3'-UTRs)负向调节 S100P 的水平。一系列功能实验表明,上调 miR-495 或 S100P 敲低抑制胰腺腺癌细胞增殖、侵袭,并促进细胞凋亡。此外,S100P 的表达与 TCGA 胰腺腺癌病例队列中 miR-495 的水平呈负相关。此外,S100P 的重新引入削弱了 miR-495 在胰腺腺癌细胞中的抗癌作用。我们的数据表明,miR-495 通过靶向 S100P 在胰腺腺癌中发挥抑制作用。

相似文献

1
S100P acts as a target of miR-495 in pancreatic cancer through bioinformatics analysis and experimental verification.通过生物信息学分析和实验验证,S100P 作为胰腺癌中 miR-495 的靶标。
Kaohsiung J Med Sci. 2021 Jul;37(7):562-571. doi: 10.1002/kjm2.12383. Epub 2021 May 5.
2
S100P promotes pancreatic cancer growth, survival, and invasion.S100P促进胰腺癌的生长、存活及侵袭。
Clin Cancer Res. 2005 Aug 1;11(15):5356-64. doi: 10.1158/1078-0432.CCR-05-0092.
3
MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG.miR-203a-3p 通过调控 SLUG 抑制胰腺癌细胞增殖、上皮间质转化和凋亡。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033819898729. doi: 10.1177/1533033819898729.
4
miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.微小RNA-367通过靶向Smad7-转化生长因子-β信号通路促进胰腺导管腺癌细胞的上皮-间质转化和侵袭。
Br J Cancer. 2015 Apr 14;112(8):1367-75. doi: 10.1038/bjc.2015.102. Epub 2015 Mar 17.
5
MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.微小RNA-377通过靶向原癌基因激酶3抑制胰腺癌的增殖。
Tumour Biol. 2016 Nov;37(11):14813-14824. doi: 10.1007/s13277-016-5295-4. Epub 2016 Sep 16.
6
LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.长链非编码 RNA ADPGK-AS1 通过激活 ZEB1 介导的上皮-间充质转化促进胰腺癌进展。
Cancer Biol Ther. 2018 Jul 3;19(7):573-583. doi: 10.1080/15384047.2018.1423912. Epub 2018 Apr 19.
7
miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.miRNA-141 在胰腺癌中下调,通过直接靶向 MAP4K4 抑制细胞增殖和侵袭。
Mol Cancer Ther. 2013 Nov;12(11):2569-80. doi: 10.1158/1535-7163.MCT-13-0296. Epub 2013 Sep 6.
8
Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.S100P对结肠腺癌不良预后的预测效率及S100P介导的侵袭和转移发病机制分析。
Cancer Genet. 2016 Apr;209(4):143-53. doi: 10.1016/j.cancergen.2016.02.002. Epub 2016 Feb 13.
9
S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer.S100P/RAGE 信号通过激活 AP-1 调控结肠癌中 microRNA-155 的表达。
Exp Cell Res. 2013 Aug 1;319(13):2081-2090. doi: 10.1016/j.yexcr.2013.05.009. Epub 2013 May 18.
10
MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX.miR-365 通过靶向衔接蛋白 SHC1 和促凋亡调节剂 BAX 诱导胰腺癌对吉西他滨产生耐药性。
Cell Signal. 2014 Feb;26(2):179-85. doi: 10.1016/j.cellsig.2013.11.003. Epub 2013 Nov 9.

引用本文的文献

1
Abnormal levels of miRNA in pancreatic cancer are linked to tumor progression by regulating the translation of tumor-associated mRNA.胰腺癌中miRNA水平异常通过调控肿瘤相关mRNA的翻译与肿瘤进展相关联。
Ann Med. 2025 Dec;57(1):2541315. doi: 10.1080/07853890.2025.2541315. Epub 2025 Aug 22.
2
Multiple roles of S100P in pan carcinoma: Biological functions and mechanisms (Review).S100P在泛癌中的多重作用:生物学功能与机制(综述)
Oncol Rep. 2025 Jun;53(6). doi: 10.3892/or.2025.8895. Epub 2025 Apr 11.
3
MicroRNA-495: a therapeutic and diagnostic tumor marker.

本文引用的文献

1
hsa_circ_001653 Implicates in the Development of Pancreatic Ductal Adenocarcinoma by Regulating MicroRNA-377-Mediated HOXC6 Axis.hsa_circ_001653通过调控MicroRNA-377介导的HOXC6轴参与胰腺导管腺癌的发生发展。
Mol Ther Nucleic Acids. 2020 Jun 5;20:252-264. doi: 10.1016/j.omtn.2019.12.028. Epub 2020 Jan 10.
2
miR-100 Inhibits Cell Growth and Proliferation by Targeting HOXA1 in Nasopharyngeal Carcinoma.miR-100通过靶向鼻咽癌中的HOXA1抑制细胞生长和增殖。
Onco Targets Ther. 2020 Jan 20;13:593-602. doi: 10.2147/OTT.S228783. eCollection 2020.
3
MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
微小 RNA-495:一种治疗和诊断肿瘤的标志物。
J Mol Histol. 2023 Dec;54(6):559-578. doi: 10.1007/s10735-023-10159-0. Epub 2023 Sep 28.
4
Screening of Therapeutic Targets for Pancreatic Cancer by Bioinformatics Methods.生物信息学方法筛选胰腺癌治疗靶点。
Horm Metab Res. 2023 Jun;55(6):420-425. doi: 10.1055/a-2007-2715. Epub 2023 Jan 4.
5
The Interaction Between Non-Coding RNAs and Calcium Binding Proteins.非编码RNA与钙结合蛋白之间的相互作用
Front Oncol. 2022 Mar 4;12:848376. doi: 10.3389/fonc.2022.848376. eCollection 2022.
MicroRNA-192 通过靶向 RB1 并激活 PI3K/AKT 通路促进鼻咽癌的发展。
World J Surg Oncol. 2020 Feb 3;18(1):29. doi: 10.1186/s12957-020-1798-y.
4
MiR-195-5p Inhibits Proliferation and Induces Apoptosis of Non-Small Cell Lung Cancer Cells by Targeting CEP55.微小RNA-195-5p通过靶向中心体蛋白55抑制非小细胞肺癌细胞的增殖并诱导其凋亡。
Onco Targets Ther. 2019 Dec 24;12:11465-11474. doi: 10.2147/OTT.S226921. eCollection 2019.
5
Downregulation of lncRNA NCK1-AS1 Inhibits Cancer Cell Migration and Invasion in Nasopharyngeal Carcinoma by Upregulating miR-135a.lncRNA NCK1-AS1的下调通过上调miR-135a抑制鼻咽癌细胞的迁移和侵袭。
Cancer Manag Res. 2019 Dec 17;11:10531-10537. doi: 10.2147/CMAR.S221326. eCollection 2019.
6
S100P is a molecular determinant of E-cadherin function in gastric cancer.S100P 是胃癌中 E-钙黏蛋白功能的分子决定因素。
Cell Commun Signal. 2019 Nov 25;17(1):155. doi: 10.1186/s12964-019-0465-9.
7
miRNA-708 functions as a tumor suppressor in colorectal cancer by targeting ZEB1 through Akt/mTOR signaling pathway.微小RNA-708通过Akt/mTOR信号通路靶向锌指E盒结合蛋白1,在结直肠癌中发挥抑癌作用。
Am J Transl Res. 2019 Sep 15;11(9):5338-5356. eCollection 2019.
8
Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.鉴定一个 4miRNA 特征作为胰腺腺癌的潜在预后生物标志物。
J Cell Biochem. 2019 Oct;120(10):16416-16426. doi: 10.1002/jcb.28601. Epub 2019 Jul 11.
9
miR-92a-3p promotes the proliferation, migration and invasion of esophageal squamous cell cancer by regulating PTEN.miR-92a-3p 通过调控 PTEN 促进食管鳞癌细胞的增殖、迁移和侵袭。
Int J Mol Med. 2019 Sep;44(3):973-981. doi: 10.3892/ijmm.2019.4258. Epub 2019 Jun 27.
10
Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update.潜在可治愈的胰腺腺癌:ASCO 临床实践指南更新。
J Clin Oncol. 2019 Aug 10;37(23):2082-2088. doi: 10.1200/JCO.19.00946. Epub 2019 Jun 10.